ARTICLE | Clinical News
oral Debio 1450: Phase I started
June 23, 2014 7:00 AM UTC
Debiopharm began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate single ascending-doses of oral Debio 1450 in up to 48 healthy subjects. An IV formulation of the product is in Phase...